The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach

Gut

Volumn 46, Issue 3, 2000, Pages 312-320

  Newton, J L ^a   Allen, A ^a   Westley, B R ^a   May, F E B ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Adherent mucus gel; Disulphide bond; Gastric; Mucin; pS2; TFF peptide

Indexed keywords

CESIUM CHLORIDE; DIMER; MONOMER; STOMACH MUCIN; TREFOIL PEPTIDE;

ARTICLE; DENSITY GRADIENT CENTRIFUGATION; DISULFIDE BOND; GASTROSCOPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH MUCOSA; STOMACH MUCUS; WESTERN BLOTTING;

BLOTTING, WESTERN; DISULFIDES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GASTRIC MUCOSA; HUMANS; MUCUS; PROTEIN CONFORMATION; PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 0034022059     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.3.312     Document Type: Article

References (39)

1. Jakowlew SB, Breathnach J-MJ, Masiakowski P, et al. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line. Nucleic Acids Res 1984;6:2861-78.
2. Rio M-C, Lepage P, Diemunsch P, et al. Structure primaire de le protéine humaine pS2. CR Acad Sci Paris 1988;307:825-31.
3. Piggott NH, Henry JA, May FEB, et al. Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry. J Pathol 1991;63:95-104.
4. Marchbank T, Westley BR, May FEB, et al. Dimerization of human pS2 (TFF1 ) plays a key role in its protective/healing effects. J Pathol 1998;185:153-8.
5. Poulsom R, Wright NA. Trefoil peptides: A newly recognized family of mucin-associated molecules. Am J Physiol 1993;265:205-13.
6. May FEB, Westley BR. Trefoil proteins: Their role in normal and malignant cells. J Pathol 1997;183:4-7.
7. Ribieras S, Tomasetto C, Rio M-C. The pS2/TFF1 trefoil factor, from basic research to clinical applications. Biochim Biophys Acta 1998;1378:F61-77.
8. Podolsky DK, Lynch-Devaney K, Stow JL, et al. Identification of human intestinal trefoil factor: Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 1993;268:6694-702.
9. Hauser F, Poulsom R, Chinery R, et al. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci USA 1993;90:6961-5.
10. Tomasetto C, Rio M-C, Gautier C, et al. hSP, the domain duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J 1990;9:407-14.
11. Gajhede M, Petersen TN, Henriksen A, et al. Pancreatic spasmolytic polypeptide (PSP): First three-dimensional structure of a member of the mammalian trefoil family of peptides. Structure 1993;1:253-62.
12. Carr MD, Bauer CJ, Gradwell MJ, et al. Solution structure of a trefoil-motif-containing cell growth factor, porcine spasmolytic protein. Proc Natl Acad Sci USA 1994;91: 2206-10.
13. Polshakov VI, Williams MA, Gargaro AR, et al. High-resolution solution structure of human pNR-2/pS2: A single trefoil motif protein. J Mol Biol 1997;267:418-32.
14. 58. Biochem J 1995;308:1001-7.
15. Chadwick MP, Westley BR, May FEB. Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58. Biochem J 1997;327:117-23.
16. Hanby AM, Poulsom R, Singh S, et al. Spasmolytic polypeptide is a major antral peptide: Distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 1993;105:1110-16.
17. Rio MC, Bellocq JP, Daniel JY, et al. Breast cancer-associated pS2 protein: Synthesis and secretion by normal stomach mucosa. Science 1988;241:705-8.
18. Itoh H, Tomita M, Uchino H, et al. cDNA cloning of rat pS2 peptide and expression of trefoil peptides in acetic acid-induced colitis. Biochem J 1996;318:939-44.
19. Lefebvre O, Wolf C, Kédinger M, et al. The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression. J Cell Biol 1993;122:191-8.
20. Lefebvre O, Chenard M-P, Masson R, et al. Gastric mucosa abnormalities and tumorigcnesis in mice lacking the pS2 trefoil protein. Science 1996;274:259-62.
21. Poulsom R. Trefoil peptides. Baillieres Clin Gastroenterol 1996;10:113-34.
22. Alison MR, Chinery R, Poulsom R, et al. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 1995; 175:405-14.
23. Playford RJ, Marchbank T, Goodlad RA, et al. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci USA 1996;93:2137-42.
24. Playford RJ, Marchbank T, Chinery R, et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995;108:108-16.
25. Babyatsky MW, deBeaumont M, Thim L, Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology 1996;110: 489-97.
26. Mashimo H, Wu D-C, Podolsky DK, et al. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996;274:262-5.
27. Dignass A, Lynch-Devaney K, Kindon H, et al. Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway. J Clin Invest 1994;94:376-83.
28. Hauser FW, Hoffman W. P-domains as shuffled cysteinerich modules in integumentary mucin (FIM-C.1) from Xenopus laevis. J Biol Chem 1992;267:24620-4.
29. Allen A, Flemström G, Garner A, et al. Gastroduodenal mucosal protection. Physiol Rev 1993;73:823-57.
30. Selleres LA, Allen A, Morris ER, et al. Mucus glycoprotein gels role of glycoprotein polymeric structure and carbohydrate side-chains in gel-formation. Carbohydrate Res 1988;178:93-110.
31. Kindon H, Pothoulakis C, Thim L, et al. Trefoil peptide protection of intestinal epithelial barrier function: Cooperative interaction with mucin glycoprotein. Gastroenterology 1995;109:516-23.
32. Jeffrey GP, Oates PS, Wang TC, et al. Spasmolytic polypeptide: A trefoil peptide secreted by rat gastric mucous cells. Gastroenterology 1994;106:336-45.
33. Tanaka S, Podolsky DK, Engel E, et al. Human spasmolytic polypeptide decreases proton permeation through gastric mucus in vivo and vitro. Am J Physiol 1997;35:G1473-80.
34. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150:76-85.
35. Mantle M, Allen A. A colorimetric assay for glycoproteins based on the periodic acid/Schiff stain. Biochem Soc Trans 1978;6:607-9.
36. Pearson J, Allen A, Venables C. Gastric mucus: Isolation and polymeric structure of the undegraded glycoprotein: Its breakdown by pepsin. Gastroenterology 1980;78:709-15.
37. Newton JL, Jordan N, Oliver L, et al. Helicobacter pylori in vivo causes structural changes in the adherent gastric mucus layer but barrier thickness is not compromised. Gut 1998:43:470-5.
38. Jordan N, Newton J, Pearson J, et al. A novel method for the visualisation of the in situ mucus layer in rat and man. Clin Sci 1998;95:97-106.
39. Henry JA, Piggott NH, Mallick UK, et al. pNR-2/pS2 immunohistochemical staining in breast cancer: Correlation with prognostic factors and endocrine response. Br J Cancer 1991;63:615-22.